The implication of semaphorins in cancer development was first suggested by the observation of a deletion of chromosomal region 3p21, where Sema3B and Sema3F reside, in almost all cases of small cell lung cancer (SCLC) [60–62]. This evidence concerns the gene SEMA3F and small cell lung carcinoma.